PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2006
CASE
AUTH/1795/2/06 Merck Sharp & Dohme

MSD held responsible for third‑party email banner missing generic name (Maxalt) – AUTH/1795/2/06

A GP complained that an eMIMS email banner promoted β€œMAXALT” without the non‑proprietary name adjacent. Even though a third party added the…

2007
CASE
AUTH/2026/7/07 Boehringer Ingelheim

Boehringer Ingelheim: Actilyse press release implied unequivocal mortality benefit (AUTH/2026/7/07)

A global Actilyse press release on a corporate website discussed mortality figures in a way that implied an unequivocal effect on death,…

2006
CASE
AUTH/1812/3/06 Bayer

AUTH/1812/3/06: Pfizer v Bayer β€” SortEDin10 campaign and BBC celebrity interview promoted Levitra to the public

A Bayer-sponsored ED awareness campaign used a celebrity spokesperson. In a BBC interview he compared Viagra, Cialis and Levitra, implying Levitra worked…

Merck Sharp & Dohme ⭐ Case of the Week

MSD rep’s Chinese restaurant meeting: unclear educational content and unsuitable venue led to Clause 2 breach

Anonymous photos alleged doctors and wives entertained at a Chinese restaurant. With no agenda/invitation and a public venue, the Panel found the…

2006
CASE
AUTH/1861/7/06 Ferring Pharmaceuticals

Anonymous v Ferring (AUTH/1861/7/06): Polo ground sponsorship signage – no breach

Anonymous complaint about Ferring logo boards at a polo ground. Panel found the signage was non-promotional and the complaint lacked detail; no…

Pfizer

Pfizer: Exubera materials criticised for missing cost information (no breach)

A GP said Exubera ads, a website and letters were misleading because price wasn’t stated. Panel accepted β€œprice yet to be agreed”…

2011
CASE
AUTH/2381/1/11 Allergan

AUTH/2381/1/11 – Director/Merz Pharma v Allergan (Alleged breach of undertaking)

PMCPA case AUTH/2381/1/11: complaint about an alleged breach of undertaking. Outcome: no breach because the matter was outwith the scope of the…

2012
CASE
AUTH/2512/6/12 Boehringer Ingelheim

AUTH/2512/6/12: Anonymous v Boehringer Ingelheim (Twitter messages) β€” No breach (outwith scope)

Anonymous complaint about Twitter messages involving Boehringer Ingelheim. PMCPA concluded the matter was outwith the scope of the ABPI Code of Practice;…

2018
CASE
AUTH/3103/10/18 Ipsen ⭐ Case of the Week

Ipsen found in breach for Cabometyx meeting discussion that advocated a lower starting dose (AUTH/3103/10/18)

PMCPA ruled Ipsen breached Clause 3.2 after a speaker said they often started older/smaller patients on 40mg Cabometyx, inconsistent with the SPC.…

2016
CASE
AUTH/2896/11/16 Janssen

AUTH/2896/11/16 – Director v Janssen (Invokana): Clinical trial disclosure

PMCPA case AUTH/2896/11/16 (Director v Janssen) concerning clinical trial disclosure for Invokana. Outcome: No breach; matter was outwith the scope of the…

2020
CASE
AUTH/3297/1/20 Britannia

Britannia: Member of the public attended Apo-go promotional meeting at MDS Congress (AUTH/3297/1/20)

At an MDS Congress satellite meeting, Britannia failed to prevent a non-HCP spouse/partner attending where Apo-go was promoted. PMCPA ruled breaches of…

2020
CASE
AUTH/3315/3/20 Novo Nordisk

AUTH/3315/3/20: Anonymous v Novo Nordisk (LinkedIn obesity stigma posts) – No breach

Complaint about Novo Nordisk employees’ LinkedIn posts on World Obesity Day (eg β€œobesity is not a choice”). Panel and Appeal Board found…

2019
CASE
Boehringer Ingelheim

Boehringer Ingelheim breached Clause 4.3 after omitting generic names next to Spiolto/Spiriva brand names on hosted webpage

A Respimat promotional video page on Guidelines in Practice included links to Spiolto and Spiriva prescribing information but did not show the…

2020
CASE
AUTH/3367/7/20 GlaxoSmithKline ⭐ Case of the Week

GSK Duac banner ad on Pulse Today: complaint about missing prescribing information (AUTH/3367/7/20) – No breach

A UK health professional said a Duac 5% Pulse Today banner was static and lacked prescribing info. GSK said it was a…

2019
CASE
AUTH/3195/4/19 Chiesi

AUTH/3195/4/19: Anonymous v Chiesi (sponsored COPD therapy review service) – No breach

Anonymous group alleged a third-party therapy review provider linked client products to reviews via an internal email. Panel and Appeal Board had…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training